WHO ICTRP trial
Evaluation of the immune response against COVID-19 in pediatric Cancer patients…
DRKS00025254 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00025254 |
|---|---|
| Public title | Evaluation of the immune response against COVID-19 in pediatric Cancer patients after vaccination |
| Scientific title | Evaluation of the immune response against COVID-19 in pediatric Cancer patients after vaccination - COV-PEDONK |
| Primary sponsor | Pädiatrische Hämatologie und OnkologieKlinik für Kinder- und JugendmedizinJohann Wolfgang Goethe Universität |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | Need for vaccination against COVID-19 C91 C92;Lymphoid leukaemia;Myeloid leukaemia |
| Interventions | Group 1: Vaccination against SARSD-CoV-2 according to approval Status; Evaluation of celllular and humaral immunity after vaccination (after first vaccination, 2 weeks and 6 moinths after seciond vaccination) |
| Registration date | May 26, 2021 |
| Target size | 100 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: